These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 22622469)
1. Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases. Viganò L; Capussotti L; Barroso E; Nuzzo G; Laurent C; Ijzermans JN; Gigot JF; Figueras J; Gruenberger T; Mirza DF; Elias D; Poston G; Letoublon C; Isoniemi H; Herrera J; Sousa FC; Pardo F; Lucidi V; Popescu I; Adam R Ann Surg Oncol; 2012 Sep; 19(9):2786-96. PubMed ID: 22622469 [TBL] [Abstract][Full Text] [Related]
2. Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial. Primrose J; Falk S; Finch-Jones M; Valle J; O'Reilly D; Siriwardena A; Hornbuckle J; Peterson M; Rees M; Iveson T; Hickish T; Butler R; Stanton L; Dixon E; Little L; Bowers M; Pugh S; Garden OJ; Cunningham D; Maughan T; Bridgewater J Lancet Oncol; 2014 May; 15(6):601-11. PubMed ID: 24717919 [TBL] [Abstract][Full Text] [Related]
3. Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases. Stremitzer S; Stift J; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T Eur J Surg Oncol; 2015 Jul; 41(7):868-74. PubMed ID: 25865557 [TBL] [Abstract][Full Text] [Related]
4. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Adam R; Pascal G; Castaing D; Azoulay D; Delvart V; Paule B; Levi F; Bismuth H Ann Surg; 2004 Dec; 240(6):1052-61; discussion 1061-4. PubMed ID: 15570210 [TBL] [Abstract][Full Text] [Related]
5. Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified? Brouquet A; Overman MJ; Kopetz S; Maru DM; Loyer EM; Andreou A; Cooper A; Curley SA; Garrett CR; Abdalla EK; Vauthey JN Cancer; 2011 Oct; 117(19):4484-92. PubMed ID: 21446046 [TBL] [Abstract][Full Text] [Related]
6. Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. Scoggins CR; Campbell ML; Landry CS; Slomiany BA; Woodall CE; McMasters KM; Martin RC Ann Surg Oncol; 2009 Jan; 16(1):35-41. PubMed ID: 18987915 [TBL] [Abstract][Full Text] [Related]
7. Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial. Garufi C; Torsello A; Tumolo S; Ettorre GM; Zeuli M; Campanella C; Vennarecci G; Mottolese M; Sperduti I; Cognetti F Br J Cancer; 2010 Nov; 103(10):1542-7. PubMed ID: 20959822 [TBL] [Abstract][Full Text] [Related]
8. A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases. Chun YJ; Kim SG; Lee KW; Cho SH; Kim TW; Baek JY; Park YS; Hong S; Chu CW; Beom SH; Jung M; Shin SJ; Ahn JB Clin Colorectal Cancer; 2020 Sep; 19(3):e140-e150. PubMed ID: 32402681 [TBL] [Abstract][Full Text] [Related]
10. Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes. DʼAngelica MI; Correa-Gallego C; Paty PB; Cercek A; Gewirtz AN; Chou JF; Capanu M; Kingham TP; Fong Y; DeMatteo RP; Allen PJ; Jarnagin WR; Kemeny N Ann Surg; 2015 Feb; 261(2):353-60. PubMed ID: 24646562 [TBL] [Abstract][Full Text] [Related]
11. Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery? Vigano L; Darwish SS; Rimassa L; Cimino M; Carnaghi C; Donadon M; Procopio F; Personeni N; Del Fabbro D; Santoro A; Torzilli G Ann Surg Oncol; 2018 Jun; 25(6):1676-1685. PubMed ID: 29488188 [TBL] [Abstract][Full Text] [Related]
12. [Preoperative chemotherapy in the surgical treatment of colorectal liver metastases]. Dede K; Láng I; Pörneczi B; Mester G; Fekete A; Kőszegi G; Mersich T; Besznyák I; Bursics A Magy Seb; 2013 Dec; 66(6):325-30. PubMed ID: 24333977 [TBL] [Abstract][Full Text] [Related]
13. Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases. Wang Y; Yuan YF; Lin HC; Li BK; Wang FH; Wang ZQ; Ding PR; Chen G; Wu XJ; Lu ZH; Pan ZZ; Wan DS; Sun P; Yan SM; Xu RH; Li YH Chin J Cancer; 2017 Oct; 36(1):78. PubMed ID: 28969708 [TBL] [Abstract][Full Text] [Related]
14. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. Shindoh J; Loyer EM; Kopetz S; Boonsirikamchai P; Maru DM; Chun YS; Zimmitti G; Curley SA; Charnsangavej C; Aloia TA; Vauthey JN J Clin Oncol; 2012 Dec; 30(36):4566-72. PubMed ID: 23150701 [TBL] [Abstract][Full Text] [Related]
15. Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases. Dexiang Z; Li R; Ye W; Haifu W; Yunshi Z; Qinghai Y; Shenyong Z; Bo X; Li L; Xiangou P; Haohao L; Lechi Y; Tianshu L; Jia F; Xinyu Q; Jianmin X Ann Surg Oncol; 2012 Sep; 19(9):2860-8. PubMed ID: 22526903 [TBL] [Abstract][Full Text] [Related]
16. Possibility of sandwiched liver surgery with molecular targeting drugs, cetuximab and bevacizumab on colon cancer liver metastases: a case report. Toyama Y; Ushigome T; Watanabe K; Kitamura H; Onda S; Saito R; Yoshida S; Kawahara H; Yanagisawa S; Yanaga K World J Surg Oncol; 2012 Jun; 10():129. PubMed ID: 22747970 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia. Yi JH; Kim H; Jung M; Shin SJ; Choi JS; Choi GH; Baik SH; Min BS; Kim NK; Ahn JB Oncology; 2013; 85(5):283-9. PubMed ID: 24217184 [TBL] [Abstract][Full Text] [Related]
18. Comparison of cetuximab to bevacizumab as the first-line bio-chemotherapy for patients with metastatic colorectal cancer: superior progression-free survival is restricted to patients with measurable tumors and objective tumor response--a retrospective study. Yang YH; Lin JK; Chen WS; Lin TC; Yang SH; Jiang JK; Lan YT; Lin CC; Yen CC; Tzeng CH; Teng HW J Cancer Res Clin Oncol; 2014 Nov; 140(11):1927-36. PubMed ID: 24934725 [TBL] [Abstract][Full Text] [Related]
19. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. Blazer DG; Kishi Y; Maru DM; Kopetz S; Chun YS; Overman MJ; Fogelman D; Eng C; Chang DZ; Wang H; Zorzi D; Ribero D; Ellis LM; Glover KY; Wolff RA; Curley SA; Abdalla EK; Vauthey JN J Clin Oncol; 2008 Nov; 26(33):5344-51. PubMed ID: 18936472 [TBL] [Abstract][Full Text] [Related]